(Q36283415)

13 August 2017

1 reference

title

Nonorgan specific autoantibodies and heart damage (English)

1 reference

13 August 2017

1 reference

1

A Tincani

1 reference

13 August 2017

C Biasini-Rebaioli

2

1 reference

13 August 2017

R Cattaneo

series ordinal

3

1 reference

13 August 2017

P Riboldi

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

656-659

1 reference

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Autoantibody-mediated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Atherosclerosis as an autoimmune disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2194OA

10.1191/0961203305LU2194OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference